Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$980M |
| 2 |
Humana
HUM
|
+$637M |
| 3 |
Apple
AAPL
|
+$620M |
| 4 |
Home Depot
HD
|
+$541M |
| 5 |
Microsoft
MSFT
|
+$539M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$770M |
| 2 |
McDonald's
MCD
|
+$654M |
| 3 |
Cigna
CI
|
+$498M |
| 4 |
Digital Realty Trust
DLR
|
+$430M |
| 5 |
Amazon
AMZN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.91% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2% |
| 4 | Industrials | 1.79% |
| 5 | Financials | 1.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13401
CALL
Passage Bio
PASG
$14.8M
| $4.34K | ﹤0.01% |
330
+245
| +288% | +$4.02K |
|
13402
CALL
Milestone Pharmaceuticals
MIST
$137M
| $4.34K | ﹤0.01% |
1,400
+1,300
| +1,300% | +$4.04K |
|
13403
PUT
Telos
TLS
$339M
| $4.3K | ﹤0.01% |
1,800
-800
| -31% | -$1.83K |
|
|
UFAB
13404
DELISTED
Unique Fabricating, Inc.
UFAB
| $4.3K | ﹤0.01% |
+18,820
| New | +$4.24K |
|
|
RJET
13405
PUT
Republic Airways Holdings
RJET
$952M
| $4.29K | ﹤0.01% |
333
-234
| -41% | -$6.07K |
|
13406
PUT
Kite Realty
KRG
$5.3B
| $4.28K | ﹤0.01% |
200
-3,900
| -95% | -$88.3K |
|
|
BSQR
13407
PUT
DELISTED
BSQUARE Corporation
BSQR
| $4.28K | ﹤0.01% |
3,600
| – | – |
|
13408
Genprex
GNPX
$2.18M
| – | – |
0
| – | – |
|
13409
Fusion Fuel Green
HTOO
$16.8M
| $4.26K | ﹤0.01% |
133
-2,144
| -94% | -$135K |
|
13410
PUT
Direxion Daily Dow Jones Internet Bear 3X ETF
WEBS
$7.06M
| $4.26K | ﹤0.01% |
+30
| New | +$3.84K |
|
13411
PUT
Crown Crafts
CRWS
$30.7M
| $4.24K | ﹤0.01% |
900
-900
| -50% | -$4.46K |
|
13412
PUT
Identive
INVE
$64.1M
| $4.22K | ﹤0.01% |
500
+100
| +25% | +$831 |
|
13413
XWELL
XWEL
$8.28M
| $4.21K | ﹤0.01% |
+1,871
| New | +$8.16K |
|
13414
CALL
Century Therapeutics
IPSC
$348M
| $4.2K | ﹤0.01% |
2,100
+700
| +50% | +$1.86K |
|
13415
BeyondSpring
BYSI
$34.5M
| $4.18K | ﹤0.01% |
5,232
| – | – |
|
13416
Delcath Systems
DCTH
$581M
| $4.18K | ﹤0.01% |
1,031
-17,342
| -94% | -$81.3K |
|
13417
PUT
SmartRent
SMRT
$286M
| $4.18K | ﹤0.01% |
1,600
-12,500
| -89% | -$42.5K |
|
|
LEXXW
13418
DELISTED
Lexaria Bioscience Warrant
LEXXW
| $4.17K | ﹤0.01% |
19,877
-5,294
| -21% | -$1.27K |
|
13419
PUT
Regis Corp
RGS
$69.3M
| $4.15K | ﹤0.01% |
295
+90
| +44% | +$1.99K |
|
13420
Aquestive Therapeutics
AQST
$533M
| $4.14K | ﹤0.01% |
2,705
-582
| -18% | -$1K |
|
13421
CALL
Cytosorbents Corp
CTSO
$25.1M
| $4.14K | ﹤0.01% |
2,200
-13,900
| -86% | -$39.9K |
|
13422
CALL
United States Antimony
UAMY
$825M
| $4.13K | ﹤0.01% |
11,200
-2,000
| -15% | -$794 |
|
|
13423
PUT
Fusion Fuel Green
HTOO
$16.8M
| $4.13K | ﹤0.01% |
129
-188
| -59% | -$11.9K |
|
13424
BRC Inc
BRCC
$213M
| $4.09K | ﹤0.01% |
+1,139
| New | +$5.02K |
|
13425
CALL
Perimeter Solutions
PRM
$5.55B
| $4.09K | ﹤0.01% |
900
-700
| -44% | -$3.9K |
|
Similar funds
Ken Griffin's Q3 2023 Portfolio in Review
As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin's Q3 2023 filing shows 1,407 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.
By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
- Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
- Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
- Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
- Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
- Ken Griffin opened 1,407 new positions and closed 1,460 in Q3 2023.
- Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.
Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.